Literature DB >> 29134263

Diminished Susceptibility of African-Americans to Non-tuberculous Mycobacterial Disease.

Jerome M Reich1, Jong S Kim2.   

Abstract

The incidence of three granulomatous response diseases-sarcoidosis, tuberculosis, and non-tuberculous mycobacterial pulmonary disease-differ markedly in African-Americans versus Caucasians. In reviewing a large compendium of non-cystic-fibrosis bronchiectasis, we noted that complicating infection with non-tuberculous mycobacteria was relatively infrequent among individuals of African-American descent, confirming previous observations of their inherent resistance. Disease-specific variance among African-Americans in the efficacy of their granulomatous response suggests a nexus, a mediating, immunological mechanism. Environmentally conditioned selection of SLC11A1 (Nramp1) alleles may account for this ethnic variance.

Entities:  

Keywords:  African–American; Bronchiectasis; Non-tuberculous mycobacterial disease; Nramp1; SLC11A1; Sarcoidosis

Mesh:

Year:  2017        PMID: 29134263     DOI: 10.1007/s00408-017-0070-x

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  13 in total

1.  The natural resistance-associated macrophage protein gene in African Americans with sarcoidosis.

Authors:  M J Maliarik; K M Chen; R G Sheffer; B A Rybicki; M L Major; J Popovich; M C Iannuzzi
Journal:  Am J Respir Cell Mol Biol       Date:  2000-06       Impact factor: 6.914

2.  Sarcoid granulomas after intradermal tuberculin in normal human skin.

Authors:  H J HURLEY; W B SHELLEY
Journal:  Arch Dermatol       Date:  1960-07

Review 3.  Bronchiectasis and nontuberculous mycobacterial disease.

Authors:  David E Griffith; Timothy R Aksamit
Journal:  Clin Chest Med       Date:  2012-04-04       Impact factor: 2.878

4.  The Lady Windermere syndrome: is there a racial as well as a gender bias?

Authors:  Henry Yeager
Journal:  Chest       Date:  2008-10       Impact factor: 9.410

Review 5.  Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization.

Authors:  B A Rybicki; M Major; J Popovich; M J Maliarik; M C Iannuzzi
Journal:  Am J Epidemiol       Date:  1997-02-01       Impact factor: 4.897

6.  Incidence of clinically identified sarcoidosis in a northwest United States population.

Authors:  J M Reich; R E Johnson
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  1996-09       Impact factor: 0.670

7.  Absence of Mycobacterium avium complex disease in patients with AIDS in Uganda.

Authors:  A B Morrissey; T O Aisu; J O Falkinham; P P Eriki; J J Ellner; T M Daniel
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992

8.  Association between SLC11A1 (formerly NRAMP1) and the risk of sarcoidosis in Poland.

Authors:  Anna Dubaniewicz; Sarra E Jamieson; M Dubaniewicz-Wybieralska; Michaela Fakiola; E Nancy Miller; Jenefer M Blackwell
Journal:  Eur J Hum Genet       Date:  2005-07       Impact factor: 4.246

9.  The international epidemiology of disseminated Mycobacterium avium complex infection in AIDS. International MAC Study Group.

Authors:  C Fordham von Reyn; R D Arbeit; A N Tosteson; M A Ristola; T W Barber; R Waddell; C H Sox; R J Brindle; C F Gilks; A Ranki; C Bartholomew; J Edwards; J O Falkinham; G T O'Connor
Journal:  AIDS       Date:  1996-08       Impact factor: 4.177

10.  I/St mice hypersusceptible to Mycobacterium tuberculosis are resistant to M. avium.

Authors:  E V Kondratieva; V V Evstifeev; T K Kondratieva; S N Petrovskaya; A V Pichugin; E I Rubakova; M M Averbakh; A S Apt
Journal:  Infect Immun       Date:  2007-07-30       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.